0.019440
0.000000
0.000000
0.000000
0.017015
0.000000
0.000000
0.000000
0.016205
0.00000
0.00000
0.00000
Tyndall, J.D.
Reid, R.C.
Tyssen, D.P.
Jardine, D.K.
Todd, B.
Passmore, M.
March, D.R.
Pattenden, L.K.
Alewood, D.
Hu, S.H.
Alewood, P.F.
Birch, C.J.
Martin, J.L.
Fairlie, D.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
51.440
58.770
61.710
C4 H9 N O2
103.120
n
ALPHA-AMINOBUTYRIC ACID
L-peptide linking
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C32 H48 N4 O6 S
616.812
(10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE
non-polymer
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
O4 S -2
96.063
SULFATE ION
non-polymer
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Med.Chem.
JMCMAR
0151
0022-2623
43
3495
3504
10.1021/jm000013n
11000004
Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease.
2000
US
Biochemistry
BICHAW
0033
0006-2960
38
7978
7988
10.1021/bi990174x
Molecular Recognition of Macrocyclic Peptidomimetic Inhibitors by HIV-1 Protease.
1999
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
118
3375
3379
10.1021/ja953790z
Substrate Based Cyclic Peptidomimetics Of Phe Ile Val That Inhibit HIV-1 Protease Using a Novel Enzyme Binding Mode.
1996
US
J.Am.Chem.Soc.
JACSAT
0004
0002-7863
117
10220
10226
Regioselective Structural and Functional Mimicry Of Peptides: Design Of Hydrolytically Stable Cyclic Peptidomimetic Inhibitors Of HIV-1 Protease.
1995
10.2210/pdb1d4l/pdb
pdb_00001d4l
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
298.0
1
IMAGE PLATE
1998-05-08
RIGAKU RAXIS IIC
SINGLE WAVELENGTH
M
x-ray
1
1.54
1.0
1.54
ROTATING ANODE
RIGAKU RU200
10765.687
HIV-1 PROTEASE
3.4.23.16
Q7K, L33I, C67(ABA), C95(ABA)
2
syn
polymer
96.063
SULFATE ION
3
syn
non-polymer
616.812
(10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE
1
syn
non-polymer
18.015
water
121
nat
water
no
yes
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEI(ABA)GHKAIGTVL
VGPTPVNIIGRNLLTQIG(ABA)TLNF
PQITLWKRPLVTIRIGGQLKEALLDTGADDTVIEEMNLPGKWKPKMIGGIGGFIKVRQYDQIPVEIAGHKAIGTVLVGPT
PVNIIGRNLLTQIGATLNF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2.16
43.18
VAPOR DIFFUSION, HANGING DROP
5.5
ammonium sulfate. acetate buffer, , pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K
293.0
software
database_2
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Refinement description
Database references
Derived calculations
1
0
2000-10-11
1
1
2008-04-27
1
2
2011-07-13
1
3
2017-10-04
1
4
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
1b6j contains a similar N-terminal macrocylic
HIV-1 protease inhibitor
1b6l contains a similar N-terminal macrocylic
HIV-1 protease inhibitor
1b6n contains a similar N-terminal macrocylic
HIV-1 protease inhibitor
1b6o contains a similar N-terminal macrocylic
HIV-1 protease inhibitor
RCSB
Y
RCSB
1999-10-04
REL
REL
SO4
SULFATE ION
PI9
(10S,13S,1'R)-13-[1'-HYDROXY-2'-(N-P-AMINOBENZENESULFONYL-1''-AMINO-3''-METHYLBUTYL)ETHYL]-8,11-DIOXO-10-ISOPROPYL-2-OXA-9,12-DIAZABICYCLO [13.2.2]NONADECA-15,17,18-TRIENE
HOH
water
SF2 isolate, chemically synthesised protein corresponds to the protease from HIV-1, with 4 mutations per monomer
sample
SO4
502
2
SO4
SO4
502
A
SO4
503
2
SO4
SO4
503
A
GLC
201
3
PI9
PI9
201
A
SO4
501
2
SO4
SO4
501
B
HOH
301
4
HOH
HOH
301
A
HOH
302
4
HOH
HOH
302
A
HOH
303
4
HOH
HOH
303
A
HOH
304
4
HOH
HOH
304
A
HOH
305
4
HOH
HOH
305
A
HOH
306
4
HOH
HOH
306
A
HOH
307
4
HOH
HOH
307
A
HOH
308
4
HOH
HOH
308
A
HOH
309
4
HOH
HOH
309
A
HOH
310
4
HOH
HOH
310
A
HOH
311
4
HOH
HOH
311
A
HOH
312
4
HOH
HOH
312
A
HOH
322
4
HOH
HOH
322
A
HOH
323
4
HOH
HOH
323
A
HOH
324
4
HOH
HOH
324
A
HOH
325
4
HOH
HOH
325
A
HOH
326
4
HOH
HOH
326
A
HOH
327
4
HOH
HOH
327
A
HOH
328
4
HOH
HOH
328
A
HOH
333
4
HOH
HOH
333
A
HOH
334
4
HOH
HOH
334
A
HOH
337
4
HOH
HOH
337
A
HOH
338
4
HOH
HOH
338
A
HOH
339
4
HOH
HOH
339
A
HOH
340
4
HOH
HOH
340
A
HOH
341
4
HOH
HOH
341
A
HOH
345
4
HOH
HOH
345
A
HOH
346
4
HOH
HOH
346
A
HOH
348
4
HOH
HOH
348
A
HOH
350
4
HOH
HOH
350
A
HOH
351
4
HOH
HOH
351
A
HOH
352
4
HOH
HOH
352
A
HOH
353
4
HOH
HOH
353
A
HOH
358
4
HOH
HOH
358
A
HOH
363
4
HOH
HOH
363
A
HOH
366
4
HOH
HOH
366
A
HOH
367
4
HOH
HOH
367
A
HOH
368
4
HOH
HOH
368
A
HOH
369
4
HOH
HOH
369
A
HOH
370
4
HOH
HOH
370
A
HOH
376
4
HOH
HOH
376
A
HOH
377
4
HOH
HOH
377
A
HOH
378
4
HOH
HOH
378
A
HOH
379
4
HOH
HOH
379
A
HOH
381
4
HOH
HOH
381
A
HOH
383
4
HOH
HOH
383
A
HOH
385
4
HOH
HOH
385
A
HOH
386
4
HOH
HOH
386
A
HOH
387
4
HOH
HOH
387
A
HOH
389
4
HOH
HOH
389
A
HOH
390
4
HOH
HOH
390
A
HOH
391
4
HOH
HOH
391
A
HOH
392
4
HOH
HOH
392
A
HOH
393
4
HOH
HOH
393
A
HOH
394
4
HOH
HOH
394
A
HOH
395
4
HOH
HOH
395
A
HOH
396
4
HOH
HOH
396
A
HOH
397
4
HOH
HOH
397
A
HOH
399
4
HOH
HOH
399
A
HOH
400
4
HOH
HOH
400
A
HOH
409
4
HOH
HOH
409
A
HOH
411
4
HOH
HOH
411
A
HOH
412
4
HOH
HOH
412
A
HOH
417
4
HOH
HOH
417
A
HOH
418
4
HOH
HOH
418
A
HOH
419
4
HOH
HOH
419
A
HOH
313
4
HOH
HOH
313
B
HOH
314
4
HOH
HOH
314
B
HOH
315
4
HOH
HOH
315
B
HOH
316
4
HOH
HOH
316
B
HOH
317
4
HOH
HOH
317
B
HOH
318
4
HOH
HOH
318
B
HOH
319
4
HOH
HOH
319
B
HOH
320
4
HOH
HOH
320
B
HOH
321
4
HOH
HOH
321
B
HOH
329
4
HOH
HOH
329
B
HOH
330
4
HOH
HOH
330
B
HOH
331
4
HOH
HOH
331
B
HOH
332
4
HOH
HOH
332
B
HOH
335
4
HOH
HOH
335
B
HOH
336
4
HOH
HOH
336
B
HOH
342
4
HOH
HOH
342
B
HOH
343
4
HOH
HOH
343
B
HOH
344
4
HOH
HOH
344
B
HOH
347
4
HOH
HOH
347
B
HOH
349
4
HOH
HOH
349
B
HOH
354
4
HOH
HOH
354
B
HOH
355
4
HOH
HOH
355
B
HOH
356
4
HOH
HOH
356
B
HOH
357
4
HOH
HOH
357
B
HOH
359
4
HOH
HOH
359
B
HOH
360
4
HOH
HOH
360
B
HOH
361
4
HOH
HOH
361
B
HOH
362
4
HOH
HOH
362
B
HOH
364
4
HOH
HOH
364
B
HOH
365
4
HOH
HOH
365
B
HOH
371
4
HOH
HOH
371
B
HOH
372
4
HOH
HOH
372
B
HOH
373
4
HOH
HOH
373
B
HOH
374
4
HOH
HOH
374
B
HOH
375
4
HOH
HOH
375
B
HOH
380
4
HOH
HOH
380
B
HOH
382
4
HOH
HOH
382
B
HOH
384
4
HOH
HOH
384
B
HOH
388
4
HOH
HOH
388
B
HOH
398
4
HOH
HOH
398
B
HOH
401
4
HOH
HOH
401
B
HOH
402
4
HOH
HOH
402
B
HOH
403
4
HOH
HOH
403
B
HOH
404
4
HOH
HOH
404
B
HOH
405
4
HOH
HOH
405
B
HOH
406
4
HOH
HOH
406
B
HOH
407
4
HOH
HOH
407
B
HOH
408
4
HOH
HOH
408
B
HOH
410
4
HOH
HOH
410
B
HOH
413
4
HOH
HOH
413
B
HOH
414
4
HOH
HOH
414
B
HOH
415
4
HOH
HOH
415
B
HOH
416
4
HOH
HOH
416
B
HOH
420
4
HOH
HOH
420
B
HOH
421
4
HOH
HOH
421
B
PRO
1
n
1
PRO
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
THR
4
n
4
THR
4
A
LEU
5
n
5
LEU
5
A
TRP
6
n
6
TRP
6
A
LYS
7
n
7
LYS
7
A
ARG
8
n
8
ARG
8
A
PRO
9
n
9
PRO
9
A
LEU
10
n
10
LEU
10
A
VAL
11
n
11
VAL
11
A
THR
12
n
12
THR
12
A
ILE
13
n
13
ILE
13
A
ARG
14
n
14
ARG
14
A
ILE
15
n
15
ILE
15
A
GLY
16
n
16
GLY
16
A
GLY
17
n
17
GLY
17
A
GLN
18
n
18
GLN
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
GLU
21
n
21
GLU
21
A
ALA
22
n
22
ALA
22
A
LEU
23
n
23
LEU
23
A
LEU
24
n
24
LEU
24
A
ASP
25
n
25
ASP
25
A
THR
26
n
26
THR
26
A
GLY
27
n
27
GLY
27
A
ALA
28
n
28
ALA
28
A
ASP
29
n
29
ASP
29
A
ASP
30
n
30
ASP
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
ILE
33
n
33
ILE
33
A
GLU
34
n
34
GLU
34
A
GLU
35
n
35
GLU
35
A
MET
36
n
36
MET
36
A
ASN
37
n
37
ASN
37
A
LEU
38
n
38
LEU
38
A
PRO
39
n
39
PRO
39
A
GLY
40
n
40
GLY
40
A
ALA
41
n
41
LYS
41
A
TRP
42
n
42
TRP
42
A
ALA
43
n
43
LYS
43
A
PRO
44
n
44
PRO
44
A
ALA
45
n
45
LYS
45
A
MET
46
n
46
MET
46
A
ILE
47
n
47
ILE
47
A
GLY
48
n
48
GLY
48
A
GLY
49
n
49
GLY
49
A
ILE
50
n
50
ILE
50
A
GLY
51
n
51
GLY
51
A
GLY
52
n
52
GLY
52
A
PHE
53
n
53
PHE
53
A
ILE
54
n
54
ILE
54
A
LYS
55
n
55
LYS
55
A
VAL
56
n
56
VAL
56
A
ARG
57
n
57
ARG
57
A
GLN
58
n
58
GLN
58
A
TYR
59
n
59
TYR
59
A
ASP
60
n
60
ASP
60
A
GLN
61
n
61
GLN
61
A
ILE
62
n
62
ILE
62
A
PRO
63
n
63
PRO
63
A
VAL
64
n
64
VAL
64
A
GLU
65
n
65
GLU
65
A
ILE
66
n
66
ILE
66
A
ABA
67
n
67
ABA
67
A
GLY
68
n
68
GLY
68
A
HIS
69
n
69
HIS
69
A
LYS
70
n
70
LYS
70
A
ALA
71
n
71
ALA
71
A
ILE
72
n
72
ILE
72
A
GLY
73
n
73
GLY
73
A
THR
74
n
74
THR
74
A
VAL
75
n
75
VAL
75
A
LEU
76
n
76
LEU
76
A
VAL
77
n
77
VAL
77
A
GLY
78
n
78
GLY
78
A
PRO
79
n
79
PRO
79
A
THR
80
n
80
THR
80
A
PRO
81
n
81
PRO
81
A
VAL
82
n
82
VAL
82
A
ASN
83
n
83
ASN
83
A
ILE
84
n
84
ILE
84
A
ILE
85
n
85
ILE
85
A
GLY
86
n
86
GLY
86
A
ARG
87
n
87
ARG
87
A
ASN
88
n
88
ASN
88
A
LEU
89
n
89
LEU
89
A
LEU
90
n
90
LEU
90
A
THR
91
n
91
THR
91
A
GLN
92
n
92
GLN
92
A
ILE
93
n
93
ILE
93
A
GLY
94
n
94
GLY
94
A
ABA
95
n
95
ABA
95
A
THR
96
n
96
THR
96
A
LEU
97
n
97
LEU
97
A
ASN
98
n
98
ASN
98
A
PHE
99
n
99
PHE
99
A
PRO
1
n
1
PRO
1
B
GLN
2
n
2
GLN
2
B
ILE
3
n
3
ILE
3
B
THR
4
n
4
THR
4
B
LEU
5
n
5
LEU
5
B
TRP
6
n
6
TRP
6
B
LYS
7
n
7
LYS
7
B
ARG
8
n
8
ARG
8
B
PRO
9
n
9
PRO
9
B
LEU
10
n
10
LEU
10
B
VAL
11
n
11
VAL
11
B
THR
12
n
12
THR
12
B
ILE
13
n
13
ILE
13
B
ARG
14
n
14
ARG
14
B
ILE
15
n
15
ILE
15
B
GLY
16
n
16
GLY
16
B
GLY
17
n
17
GLY
17
B
GLN
18
n
18
GLN
18
B
LEU
19
n
19
LEU
19
B
LYS
20
n
20
LYS
20
B
ALA
21
n
21
GLU
21
B
ALA
22
n
22
ALA
22
B
LEU
23
n
23
LEU
23
B
LEU
24
n
24
LEU
24
B
ASP
25
n
25
ASP
25
B
THR
26
n
26
THR
26
B
GLY
27
n
27
GLY
27
B
ALA
28
n
28
ALA
28
B
ASP
29
n
29
ASP
29
B
ASP
30
n
30
ASP
30
B
THR
31
n
31
THR
31
B
VAL
32
n
32
VAL
32
B
ILE
33
n
33
ILE
33
B
GLU
34
n
34
GLU
34
B
GLU
35
n
35
GLU
35
B
MET
36
n
36
MET
36
B
ALA
37
n
37
ASN
37
B
LEU
38
n
38
LEU
38
B
PRO
39
n
39
PRO
39
B
GLY
40
n
40
GLY
40
B
ALA
41
n
41
LYS
41
B
TRP
42
n
42
TRP
42
B
ALA
43
n
43
LYS
43
B
PRO
44
n
44
PRO
44
B
LYS
45
n
45
LYS
45
B
MET
46
n
46
MET
46
B
ILE
47
n
47
ILE
47
B
GLY
48
n
48
GLY
48
B
GLY
49
n
49
GLY
49
B
ILE
50
n
50
ILE
50
B
GLY
51
n
51
GLY
51
B
GLY
52
n
52
GLY
52
B
PHE
53
n
53
PHE
53
B
ILE
54
n
54
ILE
54
B
LYS
55
n
55
LYS
55
B
VAL
56
n
56
VAL
56
B
ARG
57
n
57
ARG
57
B
GLN
58
n
58
GLN
58
B
TYR
59
n
59
TYR
59
B
ASP
60
n
60
ASP
60
B
GLN
61
n
61
GLN
61
B
ILE
62
n
62
ILE
62
B
PRO
63
n
63
PRO
63
B
VAL
64
n
64
VAL
64
B
GLU
65
n
65
GLU
65
B
ILE
66
n
66
ILE
66
B
ABA
67
n
67
ABA
67
B
GLY
68
n
68
GLY
68
B
HIS
69
n
69
HIS
69
B
LYS
70
n
70
LYS
70
B
ALA
71
n
71
ALA
71
B
ILE
72
n
72
ILE
72
B
GLY
73
n
73
GLY
73
B
THR
74
n
74
THR
74
B
VAL
75
n
75
VAL
75
B
LEU
76
n
76
LEU
76
B
VAL
77
n
77
VAL
77
B
GLY
78
n
78
GLY
78
B
PRO
79
n
79
PRO
79
B
THR
80
n
80
THR
80
B
PRO
81
n
81
PRO
81
B
VAL
82
n
82
VAL
82
B
ASN
83
n
83
ASN
83
B
ILE
84
n
84
ILE
84
B
ILE
85
n
85
ILE
85
B
GLY
86
n
86
GLY
86
B
ARG
87
n
87
ARG
87
B
ASN
88
n
88
ASN
88
B
LEU
89
n
89
LEU
89
B
LEU
90
n
90
LEU
90
B
THR
91
n
91
THR
91
B
GLN
92
n
92
GLN
92
B
ILE
93
n
93
ILE
93
B
GLY
94
n
94
GLY
94
B
ABA
95
n
95
ABA
95
B
THR
96
n
96
THR
96
B
LEU
97
n
97
LEU
97
B
ASN
98
n
98
ASN
98
B
PHE
99
n
99
PHE
99
B
author_and_software_defined_assembly
PISA
2
dimeric
5450
-58
9000
A
ABA
67
ALPHA-AMINOBUTYRIC ACID
A
ABA
67
ALA
A
ABA
95
ALPHA-AMINOBUTYRIC ACID
A
ABA
95
ALA
B
ABA
67
ALPHA-AMINOBUTYRIC ACID
B
ABA
67
ALA
B
ABA
95
ALPHA-AMINOBUTYRIC ACID
B
ABA
95
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
3
A
N
ILE
3
B
O
LEU
97
B
O
LEU
97
B
N
ASN
98
B
N
ASN
98
A
O
THR
96
A
O
THR
96
A
O
LEU
97
A
O
LEU
97
B
N
ILE
3
B
N
ILE
3
A
O
ILE
47
A
O
ILE
47
A
N
ILE
54
A
N
ILE
54
A
N
ILE
66
A
N
ILE
66
A
O
HIS
69
A
O
HIS
69
A
O
LEU
76
A
O
LEU
76
A
N
ILE
33
A
N
ILE
33
A
O
VAL
32
A
O
VAL
32
A
N
ILE
84
A
N
ILE
84
A
N
ILE
85
A
N
ILE
85
A
O
LEU
23
A
O
LEU
23
A
O
ALA
22
A
O
ALA
22
A
N
VAL
11
A
N
VAL
11
A
O
ARG
14
A
O
ARG
14
A
N
GLU
65
A
N
GLU
65
B
N
GLY
49
B
N
GLY
49
B
O
GLY
52
B
O
GLY
52
B
N
ILE
66
B
N
ILE
66
B
O
HIS
69
B
O
HIS
69
B
N
LEU
76
B
N
LEU
76
B
O
THR
31
B
O
THR
31
B
O
VAL
32
B
O
VAL
32
B
N
ILE
84
B
N
ILE
84
B
N
ILE
85
B
N
ILE
85
B
O
LEU
23
B
O
LEU
23
B
O
ALA
22
B
O
ALA
22
B
N
VAL
11
B
N
VAL
11
B
O
ARG
14
B
O
ARG
14
B
N
GLU
65
B
N
GLU
65
1
A
CG
LYS
41
A
CG
LYS
41
1
Y
1
A
CD
LYS
41
A
CD
LYS
41
1
Y
1
A
CE
LYS
41
A
CE
LYS
41
1
Y
1
A
NZ
LYS
41
A
NZ
LYS
41
1
Y
1
A
CG
LYS
43
A
CG
LYS
43
1
Y
1
A
CD
LYS
43
A
CD
LYS
43
1
Y
1
A
CE
LYS
43
A
CE
LYS
43
1
Y
1
A
NZ
LYS
43
A
NZ
LYS
43
1
Y
1
A
CG
LYS
45
A
CG
LYS
45
1
Y
1
A
CD
LYS
45
A
CD
LYS
45
1
Y
1
A
CE
LYS
45
A
CE
LYS
45
1
Y
1
A
NZ
LYS
45
A
NZ
LYS
45
1
Y
1
B
CG
GLU
21
B
CG
GLU
21
1
Y
1
B
CD
GLU
21
B
CD
GLU
21
1
Y
1
B
OE1
GLU
21
B
OE1
GLU
21
1
Y
1
B
OE2
GLU
21
B
OE2
GLU
21
1
Y
1
B
CG
ASN
37
B
CG
ASN
37
1
Y
1
B
OD1
ASN
37
B
OD1
ASN
37
1
Y
1
B
ND2
ASN
37
B
ND2
ASN
37
1
Y
1
B
CG
LYS
41
B
CG
LYS
41
1
Y
1
B
CD
LYS
41
B
CD
LYS
41
1
Y
1
B
CE
LYS
41
B
CE
LYS
41
1
Y
1
B
NZ
LYS
41
B
NZ
LYS
41
1
Y
1
B
CG
LYS
43
B
CG
LYS
43
1
Y
1
B
CD
LYS
43
B
CD
LYS
43
1
Y
1
B
CE
LYS
43
B
CE
LYS
43
1
Y
1
B
NZ
LYS
43
B
NZ
LYS
43
1
Y
1
A
PRO
79
-68.86
69.07
parhcsdx.pro
tophcsdx.pro
nal.par
Inhibiter1.top
toph19.sol
so4.inp
19.5
0.00
0.00
0.00
0.00
0.00
0.00
0.2310000
0.005
0.1890000
0.1890000
0.1890000
1.75
8.00
1791
18244
18244
9.8
94.9
RANDOM
10000000.00
0.001
1
RESTRAINED
THROUGHOUT
0.0
0.0
Engh & Huber
0.23
0.18
5.00
0.27
0.23
1.75
8.00
121
1721
60
0
1540
0.009
1.5
27.3
1.42
1.43
1.50
2.24
2.00
2.51
2.00
4.17
2.50
0.3200000
0.020
0.2810000
1.86
251
2459
6
9.3
86.1
10.2
1.75
50.0
1D4L
62454
59019
0.0
1.0
0.0830000
1
9.5
3.38
94.5
0.3020000
1.75
1.83
1621
3.35
84.6
model building
X-PLOR
refinement
X-PLOR
3.851
data reduction
DENZO
data scaling
SCALEPACK
phasing
X-PLOR
HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR
1
N
N
1
N
N
2
N
N
2
N
N
3
N
N
2
N
N
4
N
N
4
N
N
A
GLY
86
A
GLY
86
HELX_P
A
THR
91
A
THR
91
1
1
6
B
GLY
86
B
GLY
86
HELX_P
B
THR
91
B
THR
91
1
2
6
covale
1.331
both
A
ILE
66
A
C
ILE
66
1_555
A
ABA
67
A
N
ABA
67
1_555
covale
1.326
both
A
ABA
67
A
C
ABA
67
1_555
A
GLY
68
A
N
GLY
68
1_555
covale
1.331
both
A
GLY
94
A
C
GLY
94
1_555
A
ABA
95
A
N
ABA
95
1_555
covale
1.334
both
A
ABA
95
A
C
ABA
95
1_555
A
THR
96
A
N
THR
96
1_555
covale
1.332
both
B
ILE
66
B
C
ILE
66
1_555
B
ABA
67
B
N
ABA
67
1_555
covale
1.334
both
B
ABA
67
B
C
ABA
67
1_555
B
GLY
68
B
N
GLY
68
1_555
covale
1.334
both
B
GLY
94
B
C
GLY
94
1_555
B
ABA
95
B
N
ABA
95
1_555
covale
1.336
both
B
ABA
95
B
C
ABA
95
1_555
B
THR
96
B
N
THR
96
1_555
HYDROLASE
HIV, PROTEASE, INHIBITOR, ANTIVIRAL, HYDROLASE
POL_HV1A2
UNP
1
P03369
57
155
1D4L
1
99
P03369
A
1
1
99
57
155
1D4L
1
99
P03369
B
1
1
99
1
GLN
engineered mutation
LYS
7
1D4L
A
P03369
UNP
63
7
1
LEU
engineered mutation
ILE
33
1D4L
A
P03369
UNP
89
33
1
CYS
engineered mutation
ABA
67
1D4L
A
P03369
UNP
123
67
1
CYS
engineered mutation
ABA
95
1D4L
A
P03369
UNP
151
95
2
GLN
engineered mutation
LYS
7
1D4L
B
P03369
UNP
63
7
2
LEU
engineered mutation
ILE
33
1D4L
B
P03369
UNP
89
33
2
CYS
engineered mutation
ABA
67
1D4L
B
P03369
UNP
123
67
2
CYS
engineered mutation
ABA
95
1D4L
B
P03369
UNP
151
95
4
8
8
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
parallel
anti-parallel
anti-parallel
A
GLN
2
A
GLN
2
A
THR
4
A
THR
4
B
THR
96
B
THR
96
B
ASN
98
B
ASN
98
A
THR
96
A
THR
96
A
ASN
98
A
ASN
98
B
GLN
2
B
GLN
2
B
THR
4
B
THR
4
A
LYS
43
A
LYS
43
A
GLY
48
A
GLY
48
A
PHE
53
A
PHE
53
A
ILE
66
A
ILE
66
A
HIS
69
A
HIS
69
A
VAL
77
A
VAL
77
A
VAL
32
A
VAL
32
A
ILE
33
A
ILE
33
A
ILE
84
A
ILE
84
A
ILE
85
A
ILE
85
A
GLN
18
A
GLN
18
A
LEU
24
A
LEU
24
A
LEU
10
A
LEU
10
A
ILE
15
A
ILE
15
A
PHE
53
A
PHE
53
A
ILE
66
A
ILE
66
B
LYS
43
B
LYS
43
B
GLY
49
B
GLY
49
B
GLY
52
B
GLY
52
B
ILE
66
B
ILE
66
B
HIS
69
B
HIS
69
B
GLY
78
B
GLY
78
B
THR
31
B
THR
31
B
GLU
34
B
GLU
34
B
ILE
84
B
ILE
84
B
ILE
85
B
ILE
85
B
GLN
18
B
GLN
18
B
LEU
24
B
LEU
24
B
LEU
10
B
LEU
10
B
ILE
15
B
ILE
15
B
GLY
52
B
GLY
52
B
ILE
66
B
ILE
66
BINDING SITE FOR RESIDUE SO4 B 501
B
SO4
501
Software
6
BINDING SITE FOR RESIDUE SO4 A 502
A
SO4
502
Software
5
BINDING SITE FOR RESIDUE SO4 A 503
A
SO4
503
Software
4
BINDING SITE FOR RESIDUE PI9 A 201
A
PI9
201
Software
22
A
GLY
68
A
GLY
68
6
3_545
A
HIS
69
A
HIS
69
6
3_545
A
LYS
70
A
LYS
70
6
3_545
A
HOH
353
G
HOH
6
3_545
B
PRO
1
B
PRO
1
6
2_554
B
LYS
55
B
LYS
55
6
1_555
A
PRO
1
A
PRO
1
5
1_555
A
ABA
67
A
ABA
67
5
1_555
A
HIS
69
A
HIS
69
5
1_555
A
HOH
363
G
HOH
5
1_555
A
HOH
417
G
HOH
5
1_555
A
ARG
14
A
ARG
14
4
1_555
B
ARG
14
B
ARG
14
4
1_455
B
GLY
16
B
GLY
16
4
1_455
B
GLY
17
B
GLY
17
4
1_455
A
ASP
25
A
ASP
25
22
1_555
A
GLY
27
A
GLY
27
22
1_555
A
ALA
28
A
ALA
28
22
1_555
A
ASP
29
A
ASP
29
22
1_555
A
GLY
48
A
GLY
48
22
1_555
A
GLY
49
A
GLY
49
22
1_555
A
ILE
50
A
ILE
50
22
1_555
A
PRO
81
A
PRO
81
22
1_555
A
VAL
82
A
VAL
82
22
1_555
A
ILE
84
A
ILE
84
22
1_555
A
HOH
301
G
HOH
22
1_555
B
ARG
8
B
ARG
8
22
1_555
B
ASP
25
B
ASP
25
22
1_555
B
GLY
27
B
GLY
27
22
1_555
B
ALA
28
B
ALA
28
22
1_555
B
ASP
30
B
ASP
30
22
1_555
B
VAL
32
B
VAL
32
22
1_555
B
GLY
48
B
GLY
48
22
1_555
B
GLY
49
B
GLY
49
22
1_555
B
ILE
50
B
ILE
50
22
1_555
B
VAL
82
B
VAL
82
22
1_555
B
ILE
84
B
ILE
84
22
1_555
19
P 21 21 21